glp-1 drug novo nordisk Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say Scoring 2 Million Prescriptions, Novo's

These include situations where metformin is ineffective, contraindicated, or when patients fail to reach their target glycemic control despite treatment with metformin and other medications

Bottom line: CagriSema could become the go-to option for patients who want more than Ozempic alone can offer, especially those struggling with fatty liver disease or stubborn appetite control

Billington CJ, Briggs JE, Link JG, et al

And we have only a couple minutes left

Todays gaming experience rarely starts on a desktop alone, and the shift toward handheld play is substantial

Many plaintiffs claim they required hospitalization, emergency treatment, surgery, specialist care, or long-term medical monitoring after developing complications associated with GLP-1 medications